Why the market has missed a trick for this weight loss drug

Joanne TranMarkets reporter

Updated Feb 20, 2025 – 3.57pm, first published at 3.55pm

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Already a subscriber?

Wendy Herringer is a portfolio manager of Northcape Capital’s global equities fund. The Sydney-based firm oversees about $14.5 billion in assets.

Shares in Ozempic maker Novo Nordisk have fallen more than 40 per cent since the highs of last year. Why are you still invested in this stock?

Joanne Tran is a markets reporter for The Australian Financial Review in the Sydney newsroom.

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Already a subscriber?

Introducing your Newsfeed

Follow the topics, people and companies that matter to you.

Fetching latest articles